1
NR 507 Advanced Pathophysiology Midterm Exam | Latest Update |
Comprehensive Practice Questions & Answers | Nursing Study Guide
& Exam Preparation PDF
1. A patient with asthma presents with wheezing, coughing, and chest tightness. Which
pathophysiological mechanism is primarily responsible for these symptoms?
A) Excessive mucus production only
B) Bronchial smooth muscle hypertrophy and airway inflammation
C) Alveolar wall destruction
D) Pulmonary hypertension
Rationale: Asthma pathophysiology involves airway inflammation, bronchial hyper-reactivity,
and smooth muscle spasm leading to airflow obstruction. While mucus production occurs, the
primary mechanism involves inflammation and bronchoconstriction.
2. Which layer of the bronchioles contains immune cells that contribute to the
inflammatory response in asthma?
A) Innermost layer
B) Middle layer (lamina propria)
C) Outermost layer
D) Basement membrane
,2
Rationale: The lamina propria is embedded with connective tissue cells and immune cells. In
asthma, these white blood cells go into overdrive, causing an inflammatory response that
damages host tissue.
3. A patient with asthma experiences alveolar hyperinflation. What is the most likely cause
of this condition?
A) Decreased mucus production
B) Bronchial wall collapse around mucus plugs trapping air
C) Increased alveolar elasticity
D) Decreased airway resistance
Rationale: The ongoing inflammatory process of asthma produces mucus and pus plugs that
cause bronchial walls to collapse around them, trapping air inside the alveoli and preventing
normal exhalation.
4. Which acid-base disorder is most likely to develop in a patient with alveolar
hyperinflation and CO2 retention?
A) Respiratory alkalosis
B) Metabolic acidosis
C) Respiratory acidosis
D) Metabolic alkalosis
Rationale: Hyperinflation of the alveoli causes retention of carbon dioxide (hypercapnia), which
leads to respiratory acidosis due to impaired gas exchange and CO2 elimination.
,3
5. A patient with asthma is prescribed an anticholinergic medication. What is the primary
mechanism of action of this drug class?
A) Stimulating beta-2 receptors
B) Blocking acetylcholine binding to cholinergic receptors
C) Increasing mucus production
D) Inhibiting mast cell degranulation
Rationale: Anticholinergic drugs block the parasympathetic nervous system by preventing
acetylcholine from binding to cholinergic receptors, thus preventing bronchial constriction and
promoting bronchodilation.
6. Which two anticholinergic medications are commonly used in the management of
asthma?
A) Albuterol and levalbuterol
B) Tiotropium and ipratropium
C) Prednisone and methylprednisolone
D) Montelukast and zafirlukast
Rationale: Tiotropium and ipratropium are anticholinergic agents that block the
parasympathetic nervous system, increasing bronchodilation by preventing acetylcholine-
induced bronchial constriction.
, 4
7. A patient with chronic bronchitis has been coughing productively for 3 consecutive
months over 2 successive years. What is the defining characteristic of this condition?
A) Intermittent cough with clear sputum
B) Chronic productive cough meeting time criteria
C) Cough only during allergy season
D) Dry cough with no sputum production
Rationale: Chronic bronchitis is characterized by bronchial inflammation, hypersecretion of
mucus, and a chronic productive cough for at least 3 consecutive months for at least 2 successive
years.
8. What pathophysiological change occurs in the bronchial smooth muscle of patients with
chronic bronchitis due to long-term irritant exposure?
A) Smooth muscle atrophy
B) Smooth muscle hypertrophy causing increased bronchoconstriction
C) Smooth muscle paralysis
D) Smooth muscle fibrosis
Rationale: Long-term exposure to irritants promotes smooth muscle hypertrophy, which causes
increased bronchoconstriction and narrowing of the airways in chronic bronchitis.
9. A patient with chronic bronchitis develops cyanosis. What pathophysiological mechanism
best explains this finding?
A) Excessive oxygen saturation
NR 507 Advanced Pathophysiology Midterm Exam | Latest Update |
Comprehensive Practice Questions & Answers | Nursing Study Guide
& Exam Preparation PDF
1. A patient with asthma presents with wheezing, coughing, and chest tightness. Which
pathophysiological mechanism is primarily responsible for these symptoms?
A) Excessive mucus production only
B) Bronchial smooth muscle hypertrophy and airway inflammation
C) Alveolar wall destruction
D) Pulmonary hypertension
Rationale: Asthma pathophysiology involves airway inflammation, bronchial hyper-reactivity,
and smooth muscle spasm leading to airflow obstruction. While mucus production occurs, the
primary mechanism involves inflammation and bronchoconstriction.
2. Which layer of the bronchioles contains immune cells that contribute to the
inflammatory response in asthma?
A) Innermost layer
B) Middle layer (lamina propria)
C) Outermost layer
D) Basement membrane
,2
Rationale: The lamina propria is embedded with connective tissue cells and immune cells. In
asthma, these white blood cells go into overdrive, causing an inflammatory response that
damages host tissue.
3. A patient with asthma experiences alveolar hyperinflation. What is the most likely cause
of this condition?
A) Decreased mucus production
B) Bronchial wall collapse around mucus plugs trapping air
C) Increased alveolar elasticity
D) Decreased airway resistance
Rationale: The ongoing inflammatory process of asthma produces mucus and pus plugs that
cause bronchial walls to collapse around them, trapping air inside the alveoli and preventing
normal exhalation.
4. Which acid-base disorder is most likely to develop in a patient with alveolar
hyperinflation and CO2 retention?
A) Respiratory alkalosis
B) Metabolic acidosis
C) Respiratory acidosis
D) Metabolic alkalosis
Rationale: Hyperinflation of the alveoli causes retention of carbon dioxide (hypercapnia), which
leads to respiratory acidosis due to impaired gas exchange and CO2 elimination.
,3
5. A patient with asthma is prescribed an anticholinergic medication. What is the primary
mechanism of action of this drug class?
A) Stimulating beta-2 receptors
B) Blocking acetylcholine binding to cholinergic receptors
C) Increasing mucus production
D) Inhibiting mast cell degranulation
Rationale: Anticholinergic drugs block the parasympathetic nervous system by preventing
acetylcholine from binding to cholinergic receptors, thus preventing bronchial constriction and
promoting bronchodilation.
6. Which two anticholinergic medications are commonly used in the management of
asthma?
A) Albuterol and levalbuterol
B) Tiotropium and ipratropium
C) Prednisone and methylprednisolone
D) Montelukast and zafirlukast
Rationale: Tiotropium and ipratropium are anticholinergic agents that block the
parasympathetic nervous system, increasing bronchodilation by preventing acetylcholine-
induced bronchial constriction.
, 4
7. A patient with chronic bronchitis has been coughing productively for 3 consecutive
months over 2 successive years. What is the defining characteristic of this condition?
A) Intermittent cough with clear sputum
B) Chronic productive cough meeting time criteria
C) Cough only during allergy season
D) Dry cough with no sputum production
Rationale: Chronic bronchitis is characterized by bronchial inflammation, hypersecretion of
mucus, and a chronic productive cough for at least 3 consecutive months for at least 2 successive
years.
8. What pathophysiological change occurs in the bronchial smooth muscle of patients with
chronic bronchitis due to long-term irritant exposure?
A) Smooth muscle atrophy
B) Smooth muscle hypertrophy causing increased bronchoconstriction
C) Smooth muscle paralysis
D) Smooth muscle fibrosis
Rationale: Long-term exposure to irritants promotes smooth muscle hypertrophy, which causes
increased bronchoconstriction and narrowing of the airways in chronic bronchitis.
9. A patient with chronic bronchitis develops cyanosis. What pathophysiological mechanism
best explains this finding?
A) Excessive oxygen saturation
